Loading...

PODCAST

The BioHub - by Avetix

Max Brennan - Biotech HeadHunter

Welcome to The BioHub, where the doors to the world of biotechnology swing wide open. Join your host, Max Brennan, a seasoned biotech recruiter, as he engages in thought-provoking conversations with the brightest minds in biotech. This podcast is your backstage pass to the insights, strategies, and stories that fuel success in the dynamic and ever-evolving biotech landscape. Subscribe now and be part of the conversation that"s shaping the future of biotechnology. Get ready for an immersive

science life sciences

All Episodes

00:25:09

Episode 183 - Matt Erick - CCO Biocon Biologics

The BioHub - by Avetix ·

2026/06/02

Matt Erick, Chief Commercial Officer for Advanced Markets at Biocon Biologics, joins Max on The BioHub Podcast.With more than two decades of experience across pharma, biologics, distribution, and healthcare services, Matt has helped shape commercial strategy across some of the industry's most complex and competitive markets.In this conversation, we discuss Biocon's expansion into the U.S., the integration of its generics and biosimilars businesses, the evolution of the biosimilars market,

en

00:23:58

Episode 182 - David Solomon - CEO of Thalia Therapeutics

The BioHub - by Avetix ·

2026/06/01

We were delighted to be joined by Dr. David Solomon, Chief Executive Officer of Thalia Therapeutics, onto The BioHub!David brings more than three decades of leadership experience across the biotechnology, pharmaceutical, and healthcare sectors, having led multiple publicly listed and private biotech companies throughout Europe and the United States. Throughout his career, he has played a key role in advancing innovative therapies, scaling organisations, securing major strategic partnerships, and

en

00:27:46

Episode 181 - Pete Smith - Co-Founder, CEO &...

The BioHub - by Avetix ·

2026/05/27

Today on the podcast, we’re joined by Peter Smith, co-founder and CEO of — a company pioneering a new frontier in RNA-processing therapeutics.Peter has spent more than two decades at the forefront of oncology and drug discovery, with leadership roles spanning Takeda, Millennium Pharmaceuticals, and H3 Biomedicine before launching Remix to tackle diseases through precision RNA modulation.Remix is working to transform patient's lives through modulation of RNA processing and addressing drug targets

en

00:27:56

Episode 180 - Ben Zimmer - CEO of Priovant Therapeutics

The BioHub - by Avetix ·

2026/05/26

In this episode of The BioHub Podcast, Max sits down with Ben Zimmer, CEO of Priovant Therapeutics.Ben was among the first ten employees at Roivant, helping incubate and launch multiple biotech companies before going on to found Priovant in 2021.Priovant is a clinical-stage biotech focused on developing therapies for severe autoimmune diseases — one of the most active and fast-moving areas in biotech today.In this conversation, we talk about the early days of Roivant, the inspiration behind building

en

00:30:07

Episode 179 - Tosh Butt - CEO of Navigator Medicines

The BioHub - by Avetix ·

2026/05/26

Tosh joins the podcast to talk through Navigator Medicines' bispecific approach to Hidradenitis Suppurativa.Giving us the full picture, from NAV-240's Korean-origins & the 2024 $100million Series A lead by RA Capital & Forbion, to the work that went into their half-life extended next-gen molecule NAV-242 & the speedy clinical development plan that could lead to a step change in HS patient outcomes.We also discuss Tosh's learnings from a career in big pharma across the likes of GSK &

en

00:34:26

Episode 179 - Kevin Finney - Chairman, President and...

The BioHub - by Avetix ·

2026/05/22

In this episode, Ben sits down with Kevin Finney, President and CEO of Autobahn Therapeutics, for a conversation on biotech leadership, CNS drug development, and what it takes to build companies around difficult but high-impact areas of medicine.Kevin brings deep experience across company formation, financing, business development, and exits, including leadership roles at Abide Therapeutics, which was acquired by Lundbeck, and Zavante Therapeutics, which was later acquired by Nabriva.We discussed

en

00:37:51

Episode 177 - Shane Hegarty - CSO & Co-Founder of...

The BioHub - by Avetix ·

2026/05/21

Today we’re joined by Shane Hegarty, a neuroscientist turned biotech operator who’s spent his career at the intersection of cutting-edge brain science and therapeutic innovation. From award-winning Parkinson’s research to helping shape the mission at Axonis Therapeutics, Shane has a front-row seat to one of the most exciting areas in medicine: repairing the nervous system. We talk about the science, the startup journey, and where neuroscience is headed next.

en

00:33:16

Episode 176 - Asa Abeliovich - CEO & Founder at Leal...

The BioHub - by Avetix ·

2026/05/20

In this episode, Ben sits down with Asa Abeliovich, MD, PhD, Founder and CEO of Leal Therapeutics, to talk about Leal’s mission to develop precision medicines for some of the most complex and underserved neurodegenerative diseases.The conversation explores how Leal is using human genetics, disease biology, and translational neuroscience to build a pipeline focused on conditions such as Parkinson’s disease, Alzheimer’s disease, and ALS. Asa discusses the rationale behind Leal’s approach, the

en

00:42:55

Episode 175 - Joe Jimenez - Co-Founder & Managing...

The BioHub - by Avetix ·

2026/05/19

Today’s guest is Joe Jimenez, one of the most influential leaders in modern biopharma. Joe previously served as CEO of Novartis, where he led the company through a major strategic transformation and helped establish it as one of the world’s leading innovative medicines companies.Today, he is the co-founder and managing director of Aditum Bio, a biotech venture firm focused on building breakthrough therapeutics companies by advancing promising science into the clinic.Aditum Bio are a new model of

en

00:33:38

Episode 174 - Bruce Leuchter - President & CEO Neurvati

The BioHub - by Avetix ·

2026/05/18

In this episode of The BioHub Podcast, Max sits down with Bruce Leuchter, co-founder and CEO of Neurvati Neurosciences.Bruce’s career spans clinical neuroscience, psychiatry, investment banking, and biotech company building — giving him a uniquely broad perspective on the future of CNS drug development.Neurvati, a Blackstone Life Sciences portfolio company, is focused on identifying and advancing high-potential therapies for neurological and psychiatric disorders.In this conversation, we discuss the

en

00:39:31

Episode 173 - Jason Silvers, President & CFO & Laurie...

The BioHub - by Avetix ·

2026/05/14

In this episode of The BioHub Podcast, Amber is joined by Jason Silvers, President & CFO at Generate:Biomedicines, and Laurie Lee, CMO for Immunology & Inflammation.Following Generate’s recent IPO, the conversation explores what it actually looks like to scale an AI-native biotech into late-stage clinical development.Amber, Jason, and Laurie discuss GB-0895 (anti-TSLP) and the global SOLAIRIA Phase 3 programme in severe asthma, designing and testing proteins at scale, and the operational

en

00:29:33

Episode 172 - Jonathan Sadeh - EVP, Head of R&D and...

The BioHub - by Avetix ·

2026/05/12

In this episode of The BioHub Podcast, Max sits down with Jonathan Sadeh, EVP, Head of R&D and Chief Medical Officer at Bausch Health.Jonathan is a physician-scientist with more than 20 years of experience across global pharma, having held senior leadership roles at Bristol Myers Squibb, Sanofi, AstraZeneca, and Schering-Plough.In this conversation, we discuss his journey through big pharma, the evolution of drug development and R&D, what it takes to progress inside large organisations, and

en

00:28:51

Episode 170 - Craig Thompson - CEO at Cerevance

The BioHub - by Avetix ·

2026/05/11

In this episode of The BioHub Podcast, Ben is joined by Craig Thompson, CEO of Cerevance.Craig has spent over three decades across biotech and pharma, leading companies through major stages of growth, development and strategic transformation. Today, he leads Cerevance, a clinical-stage neuroscience company focused on developing new medicines for neurological and neuropsychiatric diseases.In this conversation, Ben and Craig discuss Cerevance’s work in Parkinson’s disease, the challenges of late-stage

en

00:33:45

Episode 171 - Amin & Chad - Resvita Bio CEO & CTO

The BioHub - by Avetix ·

2026/05/11

In this episode of The BioHub Podcast, Max sits down with Amin Zargar, CEO of ResVita Bio, and Chad Miller, the company’s Chief Technology Officer.ResVita is developing a new class of treatments for skin diseases using engineered bacteria to deliver continuous protein therapy directly on the skin — an approach designed to transform how chronic dermatological conditions are treated.Amin brings deep expertise in synthetic biology from Jay Keasling’s lab at UC Berkeley, while Chad’s background spans

en

00:48:06

Episode 169 - nChroma Bio - Melissa Bonner (CSO) &...

The BioHub - by Avetix ·

2026/05/07

Today, we’re joined by two leaders at nChroma Bio, a company working to redefine the future of genetic medicine through epigenetic engineering and next-generation targeted delivery technologies.Melissa Bonner, Chief Scientific Officer, and Dr. Jenny Marlowe, Chief Development Officer, are helping lead the development of therapies designed not just to edit genes, but to control how genes are turned on and off — without permanently changing the underlying DNA sequence.nChroma is combining programmable

en

00:21:40

Episode 168 - Tom Frohlich - Jade Biosciences

The BioHub - by Avetix ·

2026/05/06

In this episode we welcome Tom Frohlich the CEO of Jade Biosciences

en

00:30:57

Episode 167 - James Mackay - Co-Founder, President &...

The BioHub - by Avetix ·

2026/05/06

Today’s guest is James Mackay, Chief Executive Officer of Crystalys — a biotech company tackling one of the most common yet often overlooked metabolic diseases: gout.James brings decades of experience across the biotechnology and pharmaceutical industries, including senior leadership roles and a track record of helping bring innovative therapies to market. His career spans global pharma and emerging biotech, where he’s built a reputation for translating cutting-edge science into real-world

en

00:26:38

Episode 166 - Shawn Singh - CEO at Vistagen

The BioHub - by Avetix ·

2026/05/01

In this episode ofThe BioHub Podcast by Avetix, Ben sits down with Shawn Singh, CEO of Vistagen Therapeutics, to discuss his career across biotech, venture capital, CROs, public markets, and the evolution of neuropsychiatry drug development.With more than 30 years of experience spanning private and public biotechnology, medtech, pharma, venture capital, and contract research, Shawn brings a uniquely broad perspective on what it takes to build and lead companies through different stages of growth.In

en

00:30:07

Episode 165 - Karen Lewis - CPO of Cardurion...

The BioHub - by Avetix ·

2026/04/30

In this episode of The BioHub Podcast, we’re joined by Karen Lewis, Chief People Officer at Cardurion Pharmaceuticals, to discuss her career journey through biotech, talent acquisition, HR leadership, public and private companies, and the realities of building culture in fast-growing organisations.Karen shares how her career began at the bench as a scientist before moving into recruitment, HR business partnering, and senior people leadership roles across some of the most recognised names in the life

en

00:17:56

Episode 164 - Natalia Misciatelli - CEO of AAVantgarde

The BioHub - by Avetix ·

2026/04/29

On this episode we discuss the AAVantgarde story with CEO, Natalia Misciatelli. Founded by Professor Alberto Auricchio in 2021 as a spin-out from Telethon Institute of Genetics and Medicine in Naples, we discuss their dual-vector and intein-based platforms and how the team are positioning to deliver large therapeutic genes for inherited retinal diseases. Backed by household VC names including; Forbion, Novo Holdings, & Sofinnova, Natalia and the team are pursuing game-changing prospects for

en

269 results

Similar Podcasts

Planetterrian Daily

Patrick · Nerra Network

New Books in Science, Technology, and Society

New Books Network

Scifi Friday

Radio Memories Network

The Bio Report

Levine Media Group

Waterlines: How Water Shapes Our World

jaywen